Knight Therapeutics reported 43.03 in PE Price to Earnings for its fiscal quarter ending in December of 2021.


Pe Change Date
Acasti Pharma 9.94 0.08 Mar/2021
Aurora Cannabis 23.27 9.84 Jun/2025
Cronos Group 13.62 3.83 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 20.69 1.92 Jun/2025
Knight Therapeutics 43.03 21.94 Dec/2021
Moderna 27.22 14.51 Jun/2023
Organon & Co 2.58 1.6 Jun/2025
Revvity 40.39 5.61 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 22.25 216.55 Jun/2025